中国免疫学杂志
中國免疫學雜誌
중국면역학잡지
CHINESE JOURNAL OF IMMUNOLOGY
2010年
3期
224-227
,共4页
癌迪针剂%抗肿瘤%免疫功能
癌迪針劑%抗腫瘤%免疫功能
암적침제%항종류%면역공능
AD-injection%Antitumor%Immunological function
目的:研究癌迪针剂对肿瘤的作用效果及其抗肿瘤免疫效应机制.方法:选用H22肝癌荷瘤小鼠注射癌迪针剂7天后,观察荷瘤小鼠肿瘤抑制率、胸腺、脾脏指数、淋巴细胞转化功能、腹腔巨噬细胞吞噬功能、TNF活性、IL-2及血清IFN-α水平.结果:癌迪针剂可明显抑制荷瘤小鼠肿瘤生长;能提高荷瘤小鼠的淋巴细胞转化功能;可增强巨噬细胞吞噬活性和TNF活性;能提高IL-2和IFN-α水平.结论:癌迪针剂能明显抑制荷瘤小鼠肿瘤生长,增强机体的免疫功能.
目的:研究癌迪針劑對腫瘤的作用效果及其抗腫瘤免疫效應機製.方法:選用H22肝癌荷瘤小鼠註射癌迪針劑7天後,觀察荷瘤小鼠腫瘤抑製率、胸腺、脾髒指數、淋巴細胞轉化功能、腹腔巨噬細胞吞噬功能、TNF活性、IL-2及血清IFN-α水平.結果:癌迪針劑可明顯抑製荷瘤小鼠腫瘤生長;能提高荷瘤小鼠的淋巴細胞轉化功能;可增彊巨噬細胞吞噬活性和TNF活性;能提高IL-2和IFN-α水平.結論:癌迪針劑能明顯抑製荷瘤小鼠腫瘤生長,增彊機體的免疫功能.
목적:연구암적침제대종류적작용효과급기항종류면역효응궤제.방법:선용H22간암하류소서주사암적침제7천후,관찰하류소서종류억제솔、흉선、비장지수、림파세포전화공능、복강거서세포탄서공능、TNF활성、IL-2급혈청IFN-α수평.결과:암적침제가명현억제하류소서종류생장;능제고하류소서적림파세포전화공능;가증강거서세포탄서활성화TNF활성;능제고IL-2화IFN-α수평.결론:암적침제능명현억제하류소서종류생장,증강궤체적면역공능.
Objective:In order to study the antitumor effect of AD injection and its immunological mechanisms.Methods:Liver cancer H22-bearing mice were treated with AD injection and 7 days later to observe the effect of AD injection on the inhibitory rate of tumor,indexes of thymus and spleen,lymphocytes transformation function,phagocytosis of the peritoneal macrophage,activity of TNF,the level of IL-2 and IFN-α in serum.Results:AD injection could inhibit the growth of tumor in bearing mice significantly and promote the transformation function of lymphocytes and enhance the peritoneal macrophage phagocytosis and the activities of TNF.AD injection could improve the level of IL-2 of spleen cells and IFN-α in serum.Conclusion:These results suggested that AD injection could obviously inhibit the growth of tumor and enhance the immune functions in bearing mice.